BiotechTube
Home/Nanovi/Thomas L. Andresen
TL

Thomas L. Andresen

Founder

Nanovi

Therapeutic Areas

Oncology

Nanovi Pipeline

DrugIndicationPhase
BioXmark®Soft tissue tumor marking for high-precision radiation therapy (e.g., prostate, lung, rectal cancer)Approved
PetXmark™Subcutaneous tissue marking for radiotherapy in dogs and catsCommercial